EURALIFE ApS

The principal activity of the company is to utilize distribution and licensing rights for health products. The company's activities has ceased in February 2021.

The income statement for the period 01.01.25 - 31.12.25 shows a profit of DKK 456,544 against DKK 55,014 for the period 01.01.24 - 31.12.24. The balance sheet shows equity of DKK 761,222.

The company entered into liquidation and Christian Gregersen was appointed as liquidator on July 13, 2022. The commencement of liquidation and appointment of Christian Gregrsen as liquidator was registered in the Danish Business Register on July 26, 2022. As a consequence of the liquidation, the values are adjusted to the net realisable value.

The company expects to complete the liquidation in 2026. The company has received a draft ruling from the Danish Tax Agency which, if upheld, may significantly affect the company's financial position. We refer to note 1 on page 12. Apart from this no events have occurred after the balance sheet date which significantly affect the company's financial position.

Other contingent liabilities

As part of the process of winding-up of the company, the liquidator has requested that the Danish Tax Agency issues a tax clearance certificate confirming that there are no outstanding claims against the company with respect to taxes and duties. In connection with the Danish Tax Agency’s processing of the liquidator's request for tax clearance certificate, the Danish Tax Agency has submitted a draft ruling whereby the company’s taxable income for the fiscal years 2016–2022 is adjusted. The proposal concerns adjustments relating to deductions for salaries paid to the company’s employees. The liquidator has objected to the Danish Tax Agency’s proposed adjustments on procedural grounds. Should the Danish Tax Agency’s proposal be upheld, it is expected to have a significant impact on the liquidation of the company.